Culliford S - Search Results

1

Late onset cytopenias following haematopoietic stem cell transplant associated with viral infection and cell specific antibodies.

Lucas G, Culliford S, Bendukidze N, Dahlstrom J, Grandage V, Carpenter B, Hough R. Lucas G, et al. Among authors: culliford s. Transpl Immunol. 2017 Mar;41:32-36. doi: 10.1016/j.trim.2017.02.002. Epub 2017 Feb 4. Transpl Immunol. 2017. PMID: 28167271

2

Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation.

Lucas G, Culliford S, Green F, Sidra G, Calvert A, Green A, Harrison P, Harvey J, Allen D, Smillie D, Masurekar A, Marks D, Russell N, Massey E. Lucas G, et al. Among authors: culliford s. Transfusion. 2010 Feb;50(2):334-9. doi: 10.1111/j.1537-2995.2009.02448.x. Epub 2009 Oct 23. Transfusion. 2010. PMID: 19874563

3

Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

Harvey J, Green A, Groves SJ, Cornish J, Moppett J, Cummins M, Keen L, Culliford S, Poles A, Hulme W, Li Y, Steward CG. Harvey J, et al. Among authors: culliford s. Bone Marrow Transplant. 2015 Mar;50(3):363-6. doi: 10.1038/bmt.2014.282. Epub 2015 Jan 12. Bone Marrow Transplant. 2015. PMID: 25581412

4

Improved survival in matched unrelated donor transplant for childhood ALL since the introduction of high-resolution matching at HLA class I and II.

Harvey J, Green A, Cornish J, Steward C, Cummins M, Keen L, Culliford S, Poles A, Hunt L, Breslin P, Li Y, Moppett J. Harvey J, et al. Among authors: culliford s. Bone Marrow Transplant. 2012 Oct;47(10):1294-300. doi: 10.1038/bmt.2012.8. Epub 2012 Feb 20. Bone Marrow Transplant. 2012. PMID: 22343674 Clinical Trial.

5

Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.

Ellory JC, Nash GB, Stone PC, Culliford SJ, Horwitz E, Stuart J. Ellory JC, et al. Among authors: culliford sj. Br J Pharmacol. 1992 Aug;106(4):972-7. doi: 10.1111/j.1476-5381.1992.tb14444.x. Br J Pharmacol. 1992. PMID: 1393295 Free PMC article.

6

Additive in vitro effects of anti-sickling drugs.

Stuart J, Mojiminiyi FB, Stone PC, Culliford SJ, Ellory JC. Stuart J, et al. Among authors: culliford sj. Br J Haematol. 1994 Apr;86(4):820-3. doi: 10.1111/j.1365-2141.1994.tb04836.x. Br J Haematol. 1994. PMID: 7918079

7

Specific inhibition of Ca-activated K channels in red cells by selected dihydropyridine derivatives.

Ellory JC, Culliford SJ, Smith PA, Wolowyk MW, Knaus EE. Ellory JC, et al. Among authors: culliford sj. Br J Pharmacol. 1994 Mar;111(3):903-5. doi: 10.1111/j.1476-5381.1994.tb14823.x. Br J Pharmacol. 1994. PMID: 8019767 Free PMC article.

8

Nitrendipine is a potent inhibitor of the Ca(2+)-activated K+ channel of human erythrocytes.

Ellory JC, Kirk K, Culliford SJ, Nash GB, Stuart J. Ellory JC, et al. Among authors: culliford sj. FEBS Lett. 1992 Jan 20;296(2):219-21. doi: 10.1016/0014-5793(92)80383-r. FEBS Lett. 1992. PMID: 1733781 Free article.

9

Effects of urea and oxygen tension on K flux in sickle cells.

Culliford SJ, Ellory JC, Gibson JS, Speake PF. Culliford SJ, et al. Pflugers Arch. 1998 Apr;435(5):740-2. doi: 10.1007/s004240050576. Pflugers Arch. 1998. PMID: 9479028

10

Activation of a novel organic solute transporter in mammalian red blood cells.

Culliford SJ, Bernhardt I, Ellory JC. Culliford SJ, et al. J Physiol. 1995 Dec 15;489 ( Pt 3)(Pt 3):755-65. doi: 10.1113/jphysiol.1995.sp021089. J Physiol. 1995. PMID: 8788940 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters